Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
نویسندگان
چکیده
منابع مشابه
Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies
Background More than 1 million women per year in the United States with benign breast biopsies are known to be at elevated risk for breast cancer (BC), with risk stratified on histologic categories of epithelial proliferation. Here we assessed women who had serial benign biopsies over time and how changes in the histologic classification affected BC risk. Methods In the Mayo Clinic Benign Bre...
متن کاملTreatment and survival on advanced breast cancer.
The final results of a clinical trial comparing endocrine with cytotoxic drug treatment for advanced breast cancer were analysed. Although cytotoxic treatment gave a significantly higher response rate with a remission duration comparable to that obtained with endocrine treatment, the sequence in which the two treatments were given did not appear to influence survival--except possibly in women w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: npj Precision Oncology
سال: 2021
ISSN: 2397-768X
DOI: 10.1038/s41698-021-00165-4